We have engineered and developed a highly efficient virus production system based
on a fully continuous tubular bioreactor for virus propagation and a size-based
capture chromatography step for virus purification.
These patented technologies together can be up to tenfold more efficient than current production systems and can be used for a wide range of virus particles employed in both gene therapy and vaccine applications.
Our technologies are the result of extensive technical research and validation over many years.
Learn more about our research by reading our Publications.
COMPARED TO BATCH VIRUS PRODUCTION
(20 times smaller equipments)
(save weeks or months)
(reduced manufacturing costs)